Nanotechnology to achieve Cost Efficiencies within Global Medical Devices Value Chain (TechVision)
Nanotechnology to achieve Cost Efficiencies within Global Medical Devices Value Chain (TechVision)
Leading the Way Forward for OEMs Streamlining their Global Medical Devices Value Chain
30-Sep-2016
Global
$4,950.00
Special Price $3,712.50 save 25 %
Description
Development of nanotechnology-based medical devices enables major cost reduction across the medical device value chain, as it offers very high bargaining power to suppliers of medical device OEMs (original equipment manufacturers). This research service (RS) analyzes the need for adoption of nanotechnologies in the medical devices industry, which are poised to enable creation of innovative medical device technologies that boost the overall quality of life for patients, and care providers. The RS evaluates the various technology developments within the major market segments within the global medical devices industry, such as drug delivery systems, in-vivo imaging, medical implants, and in-vitro diagnostics. From a technology perspective, the research services covers an in-depth analysis of commercial applications of nanoscale materials, nanocoatings, biomimicking materials, nano-oncology applications, and development of nano-based surgical tools.
Table of Contents
1.1 Scope of Research
1.2 Research Methodology
2.1 Broad Commercial Application of Nanotechnology in Medical Coatings
2.2 Very Low Commercial Impact of Therapeutic Applications of Nanotechnology in Non-oncology Sectors
2.3 Nanoscale Materials for Medical Devices Offer Potential to Increase Value Offered to Care Consumers
3.1 Nanomanufacturing Enable Production of Cellular-scale Sensors for High-resolution Measurements
3.2 Hydroxyapatite-coated Titanium and Tantalum Implants Offer High Commercial Market Potential
3.3 Nanocoatings Increase Biocompatibility of Medical Implants and Reduce Re-hospitalization
3.4 Nanolithography is One of the Most Widely Investigated Manufacturing Technique in the Past Decade
4.1 Research Collaboration Improves Technical Know-how on 3D Printing of Stem Cells
4.2 Nanotechnologies Alleviate Supplier's Compromise on Quality to Cost Reduction
4.3 Nanomaterials Addresses the Challenge of Bacterial Resistance to Traditional Antimicrobial Treatment
5.1 Joint Collaboration with International Research Teams Improve Precision of Rapid Prototyping
5.2 Commercialized Therapeutic Applications of Nanotechnology Supersede Diagnostic Applications
5.3 Nano-functionalization Has Very Low Impact in Increasing Biocompatibility of Cardiac Implants
5.4 Global Regulatory Scenarios Influence Production/Testing in Drug Delivery and in vitro Diagnostics
6.1 Nano-based Power Supplies for in vivo Medical Implants Reduce Surgical Replacement Costs
6.2 High Potential Licensing Agreements in Dendrimer-enhanced Nanoscale Polymer Technologies
6.3 Technology Licensing Opportunities in Fabrication of Nanomaterial-based Biosensors
6.4 Focus on Non-oncology Applications are Poised to Support Market Share Growth for Companies
7.1 Companies Rely on Strategic Partnerships with Leading Industry Participants to Gain Access to Emerging Markets
7.2 Nanotech Offers Potential for Non-healthcare Market Leaders to Diversify into Medical Devices Sector
7.3 Surface Coated Nanoparticles for Radiotherapy Have High Potential for Both Revenue and Value Growth
7.4 Out-innovate Other Companies to Maintain Market Position
8.1 High Prospects for Development of Nanoviricides for Treating Viral Diseases by 2020
9.1 Granted and Applied Patents for Drug Delivery and Medical Implants Remain Proportional to Each Other over the Past Two Decades
9.2 Key Patents: Nanoparticle Drug Delivery System and Method of Treating Cancer and Neurotrauma
9.3 Key Patent: Synthesis of Fluorescent Noble Metal Nanoparticles
9.4 Key Patent: Nanoparticles for Magnetic Resonance Imaging Tracking and Methods of Manufacturing
10.1 List of Key Industry Participants
Legal Disclaimer
11.1 The Frost & Sullivan Story
11.2 Value Proposition: Future of Your Company & Career
11.3 Global Perspective
11.4 Industry Convergence
11.5 360º Research Perspective
11.6 Implementation Excellence
11.7 Our Blue Ocean Strategy
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Arjunvasan Ambigapathy |
Industries | Healthcare |
WIP Number | D74A-01-00-00-00 |
Keyword 1 | Global Medical Devices Value Chain |
Keyword 2 | nanotechnology-based medical devices |
Keyword 3 | medical device OEMs |
Is Prebook | No |